Understanding how live biotherapeutic products (LBPs) interact with their host is central to advancing next-generation probiotic research and development. Host-microbe crosstalk refers to the complex molecular interactions between microbial agents and host epithelial, immune, or neuronal cells—interactions that influence barrier integrity, immune modulation, and microbial homeostasis. As regulatory frameworks increasingly emphasize mechanistic evidence, establishing clear, reproducible mechanisms of action (MOA) has become essential for strain characterization and product advancement.
Creative Biolabs has developed a specialized host-microbe crosstalk analysis platform to address this need. By integrating advanced multi-omics technologies, high-throughput co-culture systems, and real-time immune interaction profiling, the platform enables comprehensive evaluation of cellular signaling, gene expression, metabolite production, and downstream phenotypic responses. This enables researchers to systematically decode the functional relevance of probiotic-host interactions, identify potential biomarkers, and validate mechanistic hypotheses critical for regulatory submissions and product differentiation.
Importance of Host-Microbe Interaction Studies in Probiotic Development
Technical Importance
Probiotic interactions with host systems are often transient and context-dependent. Standard in vitro assays fail to capture the complexity of host signaling, mucosal environments, and immune responses. Creative Biolabs' integrated platform addresses these limitations by:
-
Utilizing advanced co-culture systems, such as epithelial-monocyte and organoid-microbe models.
-
Applying transcriptomic and proteomic profiling to capture host signaling responses.
-
Incorporating real-time imaging to monitor live-cell responses to microbial contact or metabolites.
-
Measuring cytokine, chemokine, and receptor-ligand interactions through multiplex assays.
Market Demand and Research Gaps
Regulatory agencies increasingly demand functional evidence of strain-specific effects in LBPs. Furthermore, investors and industry stakeholders seek mechanistic clarity to support product differentiation and claims. There is a significant market need for CRO platforms that can:
-
De-risk LBP candidates via predictive in vitro data.
-
Characterize immune and metabolic responses at the molecular level.
-
Validate functional biomarkers for downstream clinical or research use.
Creative Biolabs' platform fulfills these unmet needs through custom-designed, scalable, and regulatory-aligned assays.
Get a Quote Now →
Host-Microbe Analysis Capabilities at Creative Biolabs
Creative Biolabs offers a robust suite of capabilities that enable deep mechanistic studies of microbial-host interactions:
1. Multi-cellular Co-culture Systems
-
Caco-2, HT29-MTX, and M-SHIME™ epithelial systems
-
THP-1, U937, and PBMC-derived immune cells
-
3D intestinal organoids and gut-on-chip models
These models enable spatial and functional analysis of barrier integrity, cytokine response, and receptor activation.
2. High-Content Imaging and Fluorescence Profiling
-
Live-cell imaging using confocal and light-sheet microscopy
-
Reporter gene assays for NF-κB, AP-1, or STAT pathways
-
FISH, CLSM, and immune staining for interaction visualization
3. Omics-Based Interaction Profiling
-
Bulk and single-cell RNA sequencing to identify host gene expression patterns
-
Proteomic and metabolomic profiling of cell supernatants and lysates
-
miRNA and epigenetic regulation studies in response to probiotic exposure
4. Immunoassays and Cytokine Panels
-
Multiplex Luminex and ELISA platforms
-
Analysis of IL-6, TNF-α, IL-10, TGF-β, and other immune regulators
-
TLR signaling and inflammasome activation assays
5. Custom Data Integration and Bioinformatics
-
Pathway enrichment analysis (e.g., KEGG, GO)
-
Host-microbe interaction networks and transcription factor inference
-
Predictive modeling for microbial impact on host cell states
Workflow for Host-Microbe Interaction Studies
Our workflow is designed to ensure scientific robustness, reproducibility, and customization across project stages:
Deliverables from Creative Biolabs' Host-Microbe Crosstalk Platform
Clients can expect a full scientific package tailored to their project needs, including:
-
Validated raw and normalized data files (RNA-seq, cytokine levels, etc.)
-
High-resolution images of microbial-host interactions
-
Detailed experimental reports with statistics and pathway insights
-
Custom-built bioinformatics summaries (e.g., heatmaps, PCA, volcano plots)
-
Recommendations for next-phase development (e.g., biomarker validation, in vivo models)
All data is generated and analyzed under strict quality control protocols to ensure reliability and reproducibility.
Application Across Probiotic Research Domains
Gut Barrier Function Analysis
Probiotics may modulate tight junction proteins (e.g., ZO-1, occludin), enhancing epithelial integrity. Our platform supports transepithelial electrical resistance (TEER), permeability assays, and gene/protein expression profiling of barrier components.
Immune Modulation Studies
Determine strain-specific effects on innate and adaptive immune responses. From dendritic cell maturation to cytokine polarization, our assays enable clear interpretation of immunological outcomes.
Mucin Interaction and Goblet Cell Response
Using mucin-producing models, we analyze bacterial adhesion, mucin gene expression (e.g., MUC2, MUC5AC), and goblet cell dynamics in response to probiotic exposure.
Host Transcriptomic Remodeling
Profiling host gene expression in response to microbial contact can reveal immunometabolic shifts, including pathways like AMPK, mTOR, and MAPK signaling.
Anti-inflammatory Potential Evaluation
Identify microbial-derived factors or metabolites that suppress pro-inflammatory mediators and upregulate tolerance-associated pathways (e.g., IL-10, FOXP3).
Early-stage Mechanism Validation for IND Submissions
Generate MOA evidence that supports live biotherapeutic investigational new drug (IND) applications, providing functional proof for strain characterization.
Related Services from Creative Biolabs
To complement your host-microbe crosstalk analysis, Creative Biolabs offers a wide range of related services:
Creative Biolabs' host-microbe crosstalk analysis platform is a best-in-class solution for uncovering the molecular mechanisms behind probiotic functionality. Whether you're developing a novel strain or validating MOA for regulatory filings, our team provides the scientific depth and technical flexibility you need.
Get a Quote Now →
FAQs
What types of host models are available for studying probiotic interactions?
We offer a wide range of host models including intestinal epithelial cells, immune cells (e.g., THP-1, PBMCs), 3D organoids, and gut-on-chip systems to simulate realistic host-microbe interaction environments.
How can transcriptomic profiling help identify probiotic mechanisms of action?
Transcriptomic profiling reveals host gene expression changes after microbial exposure, enabling the identification of key signaling pathways, immune regulators, and potential biomarkers relevant to probiotic function and host response.
How do you ensure reproducibility across different microbial strains?
We standardize exposure conditions, use validated co-culture protocols, and apply quality-controlled multi-omics and immunoassay workflows to ensure consistent, strain-specific host response profiling across studies.
Other Resources
References
-
Zmora, Niv, et al. "Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features." Cell 174.6 (2018): 1388-1405. https://doi.org/10.1016/j.cell.2018.08.041
-
Jalanka-Tuovinen, Jonna, et al. "Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome." Gut 63.11 (2014): 1737-1745. https://doi.org/10.1136/gutjnl-2013-305994
-
Westermann, Alexander J., and Jörg Vogel. "Cross-species RNA-seq for deciphering host–microbe interactions." Nature Reviews Genetics 22.6 (2021): 361-378. https://doi.org/10.1038/s41576-021-00326-y
